4 Results for "

bone marrow hematopoiesis

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "bone marrow hematopoiesis" in MCE Product Catalog:

  • Oligonucleotides Recommended:
9
9 Cited Publications
Cat. No.: HY-17564
CAS No.: 3992-42-5
Synonyms: 2'-Deoxycytidine monohydrochloride; Deoxycytidine hydrochloride; NSC 83251
2'-Deoxycytidine hydrochloride (2'-Deoxycytidine monohydrochloride; NSC 83251) is an orally active nucleic acid biosynthesis enzyme inhibitor. 2'-Deoxycytidine hydrochloride competes with nucleic acid biosynthesis enzymes and nucleoside transporters, thereby reducing the toxicity of cytarabine. 2'-Deoxycytidine hydrochloride can be used in the research of L1210 lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-134259
CAS No.: 2250156-71-7
Purity:  98.97%
Target:  

HOXA

Research Areas:  

Cancer

MEISi-2 is a selective inhibitor of MEIS, a key regulator of hematopoietic stem cell (HSC) self-renewal. MEISi-2 is developed for the research of cardiac injuries, hematopoiesis issues, bone marrow transplantations, and cancer .
loading...
    loading...
Cat. No.: HY-118028
CAS No.: 1950-36-3
Purity:  99.99%
Leyk is an orally active Cysteine derivative. Leyk stimulates bone marrow hematopoiesis. Leyk exerts a significant protective effect against cyclophosphamide-induced leukopenia. Leyk can be used in studies related to thrombocytopenia and leukopenia .
loading...
    loading...
Cat. No.: HY-P991888
Target:  

STAT

Research Areas:  

Cardiovascular Disease Cancer

INCA033989 is a fully human IgG1 monoclonal antibody targeting mutCALR (KD = 1.75 nM for mutCALR del52; KD = 6.78 nM for mutCALR ins5). INCA033989 antagonizes mutCALR-driven signaling and proliferation. INCA033989 selectively inhibits pSTAT3/pSTAT5. INCA033989 prevents thrombocytosis and reduces the expansion of mutCALR-positive cells. INCA033989 is useful for research on myeloproliferative neoplasms .
loading...
    loading...